{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:48:41Z","timestamp":1793998121963,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["5P20GM109025"],"award-info":[{"award-number":["5P20GM109025"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"name":"A Woman's Nation\/Maria Shriver","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["W81XWH-12-2-0012"],"award-info":[{"award-number":["W81XWH-12-2-0012"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13195-017-0300-8","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T11:27:20Z","timestamp":1505215640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume"],"prefix":"10.1186","volume":"9","author":[{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Z. K.","family":"Caldwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody-Lynn","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,12]]},"reference":[{"key":"300_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-013-1185-7","volume":"126","author":"CR Jack Jr","year":"2013","unstructured":"Jack Jr CR, Barrio JR, Kepe V. Cerebral amyloid PET imaging in Alzheimer\u2019s disease. Acta Neuropathol. 2013;126:643\u201357.","journal-title":"Acta Neuropathol"},{"key":"300_CR2","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/cercor\/bhr271","volume":"22","author":"M Ewers","year":"2012","unstructured":"Ewers M, Insel P, Jagust WJ, Shaw L, Aisen P, Petersen RC, et al. CSF biomarker and PIB-PET-derived \u03b2-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex. 2012;22:1993\u20132004.","journal-title":"Cereb Cortex"},{"key":"300_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S1474-4422(15)00135-0","volume":"14","author":"WY Yau","year":"2015","unstructured":"Yau WY, Tudorascu DL, McDade EM, Ikonomovic S, James JA, Minhas D, et al. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2015;14:804\u201313.","journal-title":"Lancet Neurol"},{"key":"300_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/ana.23650","volume":"72","author":"SM Landau","year":"2012","unstructured":"Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, et al. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol. 2012;72:578\u201386.","journal-title":"Ann Neurol"},{"key":"300_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1212\/WNL.0000000000001903","volume":"85","author":"F Wang","year":"2015","unstructured":"Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, et al. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. 2015;85:790\u20138.","journal-title":"Neurology"},{"key":"300_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/alzrt88","volume":"3","author":"R Ossenkoppele","year":"2011","unstructured":"Ossenkoppele R, van Berckel BNM, Prins ND. Amyloid imaging in prodromal Alzheimer\u2019s disease. Alzheimers Res Ther. 2011;3:26.","journal-title":"Alzheimers Res Ther"},{"key":"300_CR7","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/brain\/awp062","volume":"132","author":"CR Jack Jr","year":"2009","unstructured":"Jack Jr CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u2019s disease: implications for sequence of pathological events in Alzheimer\u2019s disease. Brain. 2009;132:1355\u201365.","journal-title":"Brain"},{"key":"300_CR8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.neurobiolaging.2010.05.003","volume":"31","author":"LG Apostolova","year":"2010","unstructured":"Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, et al. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging. 2010;31:1284\u2013303.","journal-title":"Neurobiol Aging"},{"key":"300_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1212\/WNL.0b013e3181c918b5","volume":"74","author":"P Bourgeat","year":"2010","unstructured":"Bourgeat P, Chetelat G, Villemagne VL, Fripp J, Raniga P, Pike K, et al. \u03b2-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology. 2010;74:121\u20137.","journal-title":"Neurology"},{"key":"300_CR10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.21955","volume":"67","author":"G Ch\u00e9telat","year":"2010","unstructured":"Ch\u00e9telat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, et al. Relationship between atrophy and \u03b2-amyloid deposition in Alzheimer disease. Ann Neurol. 2010;67:317\u201324.","journal-title":"Ann Neurol"},{"key":"300_CR11","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1212\/WNL.0b013e3181a2e896","volume":"72","author":"GB Frisoni","year":"2009","unstructured":"Frisoni GB, Lorenzi M, Caroli A, Kemppainen N, Nagren K, Rinne JO. In vivo mapping of amyloid toxicity in Alzheimer disease. Neurology. 2009;72:1504\u201311.","journal-title":"Neurology"},{"key":"300_CR12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/brain\/awu043","volume":"137","author":"N Mattsson","year":"2014","unstructured":"Mattsson N, Tosun D, Insel PS, Simonson A, Jack Jr CR, Beckett LA, et al. Association of brain amyloid-\u03b2 with cerebral perfusion and structure in Alzheimer\u2019s disease and mild cognitive impairment. Brain. 2014;137:1550\u201361.","journal-title":"Brain"},{"key":"300_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000441351","volume":"41","author":"PT Trzepacz","year":"2016","unstructured":"Trzepacz PT, Hochstetler H, Yu P, Castelluccio P, Witte MM, Dell\u2019Agnello G, et al. Relationship of hippocampal volume to amyloid burden across diagnostic stages of Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2016;41:68\u201379.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"300_CR14","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1523\/JNEUROSCI.2092-14.2015","volume":"35","author":"Z Song","year":"2015","unstructured":"Song Z, Insel PS, Buckley S, Yohannes S, Mezher A, Simonson A, et al. Brain amyloid-\u03b2 burden is associated with disruption of intrinsic functional connectivity within the medial temporal lobe in cognitively normal elderly. J Neurosci. 2015;35:3240\u20137.","journal-title":"J Neurosci"},{"key":"300_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.neuroimage.2015.08.050","volume":"124","author":"A Tan","year":"2016","unstructured":"Tan A, Ma W, Vira A, Marwha D, Eliot L. The human hippocampus is not sexually-dimorphic: meta-analysis of structural MRI volumes. Neuroimage. 2016;124:350\u201366.","journal-title":"Neuroimage"},{"key":"300_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neulet.2014.04.013","volume":"570","author":"G Perlaki","year":"2014","unstructured":"Perlaki G, Orsi G, Plozer E, Altbacker A, Darnai G, Nagy SA, et al. Are there any sex differences in the hippocampus volume after head-size correction? A volumetric and voxel-based morphometric study. Neurosci Lett. 2014;570:119\u201323.","journal-title":"Neurosci Lett"},{"key":"300_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.pscychresns.2014.11.011","volume":"231","author":"R Nordenskjold","year":"2005","unstructured":"Nordenskjold R, Malmberg F, Larsson EM, Simmons A, Ahlstrom H, Johansson L, et al. Intracranial volume normalization methods: considerations when investigating gender differences in regional brain volume. Psychiatry Res Neuroimaging. 2005;231:227\u201335.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"300_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neurobiolaging.2014.07.036","volume":"36","author":"RL Nosheny","year":"2015","unstructured":"Nosheny RL, Insel PS, Truran D, Schuff N, Jack Jr CR, Aisen PS, et al. Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment. Neurobiol Aging. 2015;36:273\u201382.","journal-title":"Neurobiol Aging"},{"key":"300_CR19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3233\/JAD-150780","volume":"50","author":"BA Ardekani","year":"2015","unstructured":"Ardekani BA, Convit A, Bachman AH. Analysis of the MIRIAD data shows sex differences in hippocampal atrophy progression. J Alzheimers Dis. 2015;50:847\u201357.","journal-title":"J Alzheimers Dis"},{"key":"300_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamaneurol.2014.4821","volume":"72","author":"CR Jack Jr","year":"2015","unstructured":"Jack Jr CR, Wiste HJ, Weigand SD, Knopman DS, Vemuri P, Mielke MM, et al. Age, sex, and APOE \u03b54 effects on memory, brain structure, and \u03b2-amyloid across the adult life span. JAMA Neurol. 2015;72:511\u20139.","journal-title":"JAMA Neurol"},{"key":"300_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1037\/pag0000070","volume":"31","author":"AC McCarrey","year":"2016","unstructured":"McCarrey AC, An Y, Kitner-Triolo MH, Ferrucci L, Resnick SM. Sex differences in cognitive trajectories in clinically normal older adults. Psychol Aging. 2016;31:166\u201375.","journal-title":"Psychol Aging"},{"key":"300_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.actpsy.2012.10.005","volume":"143","author":"JM Murre","year":"2013","unstructured":"Murre JM, Janssen SM, Rouw R, Meeter M. The rise and fall of immediate and delayed memory for verbal and visuospatial information from late childhood to late adulthood. Acta Psychol (Amst). 2013;143:96\u2013107.","journal-title":"Acta Psychol (Amst)"},{"key":"300_CR23","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/13825585.2012.690366","volume":"19","author":"CA Munro","year":"2012","unstructured":"Munro CA, Winicki JM, Schretlen DJ, Gower EW, Turano KA, Mu\u00f1oz B, et al. Sex differences in cognition in healthy elderly individuals. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2012;19:759\u201368.","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"key":"300_CR24","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1212\/WNL.0000000000002570","volume":"86","author":"EE Sundermann","year":"2016","unstructured":"Sundermann EE, Biegon A, Rubin LH, Lipton RB, Mowrey W, Landau S, et al. Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy. Neurology. 2016;86:1368\u201376.","journal-title":"Neurology"},{"issue":"18","key":"300_CR25","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/WNL.0000000000003288","volume":"87","author":"EE Sundermann","year":"2016","unstructured":"Sundermann EE, Maki PM, Rubin LH, Lipton RB, Landau S, Biegon A. Female advantage in verbal memory: Evidence of sex-specific cognitive reserve. Neurology. 2016;87(18):1916\u2013924.","journal-title":"Neurology"},{"key":"300_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/CLEP.S37929","volume":"6","author":"MM Mielke","year":"2014","unstructured":"Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer\u2019s disease: assessing sex and gender differences. Clin Epidemiol. 2014;6:37\u201348.","journal-title":"Clin Epidemiol"},{"key":"300_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"300_CR28","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. Clinical Dementia Rating: current version and scoring rules. Neurology. 1993;43:2412\u201314.","journal-title":"Neurology"},{"key":"300_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74:201\u20139.","journal-title":"Neurology"},{"key":"300_CR30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.neuroimage.2010.07.020","volume":"53","author":"M Reuter","year":"2010","unstructured":"Reuter M, Rosas HD, Fischl B. Highly accurate inverse consistent registration: a robust approach. Neuroimage. 2010;53:1181\u201396.","journal-title":"Neuroimage"},{"key":"300_CR31","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.neuroimage.2004.03.032","volume":"22","author":"F S\u00e9gonne","year":"2004","unstructured":"S\u00e9gonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, et al. A hybrid approach to the skull stripping problem in MRI. Neuroimage. 2004;22:1060\u201375.","journal-title":"Neuroimage"},{"key":"300_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341\u201355.","journal-title":"Neuron"},{"issue":"Suppl 1","key":"300_CR33","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.neuroimage.2004.07.016","volume":"23","author":"B Fischl","year":"2004","unstructured":"Fischl B, Salat DH, van der Kouwe AJ, Makris N, S\u00e9gonne F, Quinn BT, et al. Sequence-independent segmentation of magnetic resonance images. Neuroimage. 2004;23 Suppl 1:S69\u201384.","journal-title":"Neuroimage"},{"key":"300_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1109\/42.668698","volume":"17","author":"JG Sled","year":"1998","unstructured":"Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998;17:87\u201397.","journal-title":"IEEE Trans Med Imaging"},{"key":"300_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1109\/42.906426","volume":"20","author":"B Fischl","year":"2001","unstructured":"Fischl B, Liu A, Dale AM. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging. 2001;20:70\u201380.","journal-title":"IEEE Trans Med Imaging"},{"key":"300_CR36","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1109\/TMI.2006.887364","volume":"26","author":"F Segonne","year":"2007","unstructured":"Segonne F, Pacheco J, Fischl B. Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging. 2007;26:518\u201329.","journal-title":"IEEE Trans Med Imaging"},{"key":"300_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 1999;9:179\u201394.","journal-title":"Neuroimage"},{"key":"300_CR38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1162\/jocn.1993.5.2.162","volume":"5","author":"AM Dale","year":"1993","unstructured":"Dale AM, Sereno MI. Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach. J Cogn Neurosci. 1993;5:162\u201376.","journal-title":"J Cogn Neurosci"},{"key":"300_CR39","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jamaneurol.2014.2031","volume":"71","author":"EC Mormino","year":"2014","unstructured":"Mormino EC, Betensky RA, Hedden T, Schultz AP, Amariglio RE, Rentz DM, et al. Synergistic effect of \u03b2-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. 2014;71:1379\u201385.","journal-title":"JAMA Neurol"},{"key":"300_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2967\/jnumed.112.109009","volume":"54","author":"SM Landau","year":"2013","unstructured":"Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust WJ, et al. Amyloid-\u03b2 imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. J Nucl Med. 2013;54:70\u20137.","journal-title":"J Nucl Med"},{"key":"300_CR41","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/archneurol.2012.510","volume":"69","author":"SM Landau","year":"2012","unstructured":"Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O\u2019Neil JP, et al. Association of lifetime cognitive engagement and low \u03b2-amyloid deposition. Arch Neurol. 2012;69:623\u20139.","journal-title":"Arch Neurol"},{"key":"300_CR42","first-page":"215","volume":"28","author":"A Rey","year":"1941","unstructured":"Rey A. L\u2019examen psychologique dans les cas d\u2019enc\u00e9phalopathie traumatique. Arch Psychol (Geneve). 1941;28:215\u201385.","journal-title":"Arch Psychol (Geneve)"},{"key":"300_CR43","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"300_CR44","volume-title":"IBM SPSS Statistics for Windows","author":"IBM","year":"2015","unstructured":"IBM. IBM SPSS Statistics for Windows. Armonk, NY: IBM; 2015."},{"key":"300_CR45","volume-title":"Introduction to mediation, moderation, and conditional process analysis: a regression based approach","author":"AF Hayes","year":"2013","unstructured":"Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression based approach. New York: Guilford Press; 2013."},{"key":"300_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11682-016-9523-8","volume":"11","author":"MEI Koran","year":"2017","unstructured":"Koran MEI, Wagener M, Hohman TJ, Alzheimer\u2019s Neuroimaging Initiative. Sex differences in the association between AD biomarkers and cognitive decline. Brain Imaging Behav. 2017;11:205\u201313.","journal-title":"Brain Imaging Behav"},{"key":"300_CR47","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/13803395.2015.1132298","volume":"38","author":"SD Gale","year":"2016","unstructured":"Gale SD, Baxter L, Thompson J. Greater memory impairment in dementing females than males, relative to sex-matched healthy controls. J Clin Exp Neuropsychol. 2016;38:527\u201333.","journal-title":"J Clin Exp Neuropsychol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-017-0300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-017-0300-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-017-0300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T21:51:33Z","timestamp":1719438693000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-017-0300-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,12]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1186\/s13195-017-0300-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,12]]},"assertion":[{"value":"10 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All data included in this article were collected for research use as part of the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) project. ADNI is a longitudinal, multisite AD biomarker study () that offers de-identified data meeting criteria for limited datasets to qualified researchers with scientific or educational institution affiliations, upon review. Ethics approval for data collection in ADNI was obtained by each ADNI participating institution\u2019s institutional review board. All participants gave written informed consent at participating institutions. The authors of this paper were granted approved access to the ADNI data, and the ADNI Data Sharing and Publications Committee (DPC) approved this paper for submission to <i>Alzheimer\u2019s Research and Therapy<\/i> (date of approval, February 24, 2017).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JZKC, JLB, and SJB declare that they have no competing interests. JLC declares having received in kind research support from Avid Radiopharmaceuticals, Teva Pharmaceuticals, and CogState; having done consultation for AbbVie, ACADIA Pharmaceuticals, Accera, Actinogen Medical, Adamas Pharmaceuticals, Alkahest, Alzheon, Anavex Life Sciences, Astellas Pharma, AstraZeneca, Avanir Pharmaceuticals, Axovant Sciences, Biogen Idec, Biotie Therapies, Boehinger Ingelheim, Chase Pharmaceuticals, Eisai, FORUM Pharmaceuticals, Genentech, Grifols, Intra-Cellular Therapies, Iris Pharma, Ionis Pharmaceuticals, Eli Lilly and Company, Lundbeck, Merck, Neurotrope BioScience, Novartis, Nutricia, Otsuka, Pfizer, Probiodrug, QR Pharma, Resverlogix, Roche, Servier, Sunovion Pharmaceuticals, Suven Life Sciences, Takeda, Taisho Toyama Pharmaceutical Co., Transition Therapeutics, United Neuroscience, GE Healthcare, and MedAvante; owning stock in Adamas Pharmaceuticals, Prana Biotechnology, Sonexa Therapeutics, MedAvante, NeuroTrax, and Neurokos; and owning the copyright of the Neuropsychiatric Inventory. In addition, JLC has provided expert witness\/legal consultation regarding olanzapine and ropinerole.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"72"}}